Pulmonary vascular disease

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
Godsfavour Umoru, Matthew Taitano, Sarah Beshay, Polly Niravath, Sandeep Sahay

ERJ Open Research Apr 2020, 6 (2) 00199-2020; DOI: 10.1183/23120541.00199-2020
Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
Karsten Keller, Lukas Hobohm, Thomas Münzel, Stavros V. Konstantinides, Mareike Lankeit

ERJ Open Research Apr 2020, 6 (2) 00181-2020; DOI: 10.1183/23120541.00181-2020
Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi

ERJ Open Research Apr 2020, 6 (2) 00218-2019; DOI: 10.1183/23120541.00218-2019
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos

ERJ Open Research Jan 2020, 6 (1) 00328-2019; DOI: 10.1183/23120541.00328-2019
Performance of pulmonary artery dimensions measured on high-resolution computed tomography scan for identifying pulmonary hypertension
Pailin Ratanawatkul, Andrea Oh, J. Caleb Richards, Jeffrey J. Swigris

ERJ Open Research Jan 2020, 6 (1) 00232-2019; DOI: 10.1183/23120541.00232-2019
Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?
Ludo F.M. Beenen, Luuk J.J. Scheres, Jaap Stoker, Saskia Middeldorp

ERJ Open Research Jan 2020, 6 (1) 00163-2019; DOI: 10.1183/23120541.00163-2019
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective
Luke Lawson McLean, Katherine Pellino, Melanie Brewis, Andrew Peacock, Martin Johnson, Alistair Colin Church

ERJ Open Research Oct 2019, 5 (4) 00241-2019; DOI: 10.1183/23120541.00241-2019
Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
Joanna Säleby, Habib Bouzina, Salaheldin Ahmed, Jakob Lundgren, Göran Rådegran

ERJ Open Research Oct 2019, 5 (4) 00037-2019; DOI: 10.1183/23120541.00037-2019
Occult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension
Maria Rosaria Gioia, Uberto Maccari, Luca Marchetti, Enivarco Maglioni, Giuseppina Ciarleglio, Valentina Granese, Laura Salerno, Luigi Spagnoli, Ilenia Zanellato, Maria Raffaella Ambrosio, Andrea Bianco, Raffaele Scala

ERJ Open Research Oct 2019, 5 (4) 00157-2019; DOI: 10.1183/23120541.00157-2019
Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016
Barbro Kjellström, Magnus Nisell, David Kylhammar, Sven-Erik Bartfay, Bodil Ivarsson, Göran Rådegran, Clara Hjalmarsson

ERJ Open Research Jul 2019, 5 (3) 00075-2019; DOI: 10.1183/23120541.00075-2019

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us